{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:29:09Z","timestamp":1780921749213,"version":"3.54.1"},"reference-count":73,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2020,2,17]]},"DOI":"10.1080\/09546634.2019.1589641","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T08:09:05Z","timestamp":1554192545000},"page":"131-140","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":38,"title":["Off-label studies on apremilast in dermatology: a review"],"prefix":"10.1080","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-5673","authenticated-orcid":false,"given":"Nolan J.","family":"Maloney","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-5434","authenticated-orcid":false,"given":"Jeffrey","family":"Zhao","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-6991","authenticated-orcid":false,"given":"Kyle","family":"Tegtmeyer","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5144-2552","authenticated-orcid":false,"given":"Ernest Y.","family":"Lee","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA, UCLA-Caltech Medical Scientist Training Program, Los Angeles, CA, USA;"},{"name":"Department of Bioengineering, UCLA, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00559.x"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X10381432"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01662"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/art.39120"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.052"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14256"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.06.027"},{"key":"CIT0008","first-page":"1224","volume":"11","author":"De Souza A","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13831"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.06.021"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2671"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.06.042"},{"key":"CIT0013","author":"Mikhaylov D","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.05.034"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2012.812"},{"key":"CIT0016","first-page":"341","volume":"11","author":"Volf EM","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.043"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408684"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.046"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.026"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.001"},{"key":"CIT0022","first-page":"221","volume":"17","author":"Stein Gold L","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.02.1164"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14647"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.301"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.07.014"},{"key":"CIT0027","first-page":"1026","volume":"15","author":"Bettencourt M","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"CIT0028","first-page":"56","volume":"10","author":"AbuHilal M","year":"2016","journal-title":"J Dermatol Case Rep"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1159\/000447051"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.10526"},{"key":"CIT0031","first-page":"801","volume":"16","author":"Strober B","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.06.017"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001047"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000843"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16897"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2191"},{"key":"CIT0037","volume":"1","author":"Hadi A","year":"2017","journal-title":"Ski J Cutan Med"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2016.6599"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.3315\/jdcr.2017.1246"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.07.007"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417712499"},{"key":"CIT0042","volume":"23","author":"Chen T","year":"2017","journal-title":"Dermatol Online J"},{"key":"CIT0043","author":"Eto A","year":"2018","journal-title":"J Dermatol"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13065"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.19104\/crcm.2016.128"},{"key":"CIT0046","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1684\/ejd.2018.3280","volume":"28","author":"Waki Y","year":"2018","journal-title":"Eur J Dermatol"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.3405"},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1684\/ejd.2017.3187","volume":"28","author":"Pellonnet L","year":"2018","journal-title":"Eur J Dermatol"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417733464"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12559"},{"key":"CIT0051","first-page":"1063","volume":"3","author":"Campanelli M","year":"2016","journal-title":"Austin J Dermatology"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2995"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.02.019"},{"key":"CIT0054","author":"Adamo S","year":"2017","journal-title":"Br J Dermatol"},{"key":"CIT0055","first-page":"2386234","author":"Huff SB","year":"2017","journal-title":"Case Rep Dermatol Med"},{"key":"CIT0056","volume-title":"A phase 2 open-label single center study to evaluate the efficacy of apremilast for the treatment of moderate hidradenitis suppurativa: NCT02695212","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0057","volume-title":"An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis: NCT03022617","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0058","volume-title":"Observational study on quality of life and echography parameters of nail psoriasis after treatment with apremilast: NCT03616561","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0059","volume-title":"A phase 3, multi-center, randomized, place-controlled, double-blind, study of the efficacy and safety of apremilast (CC-10004 in subjects with moderate to severe plaque psoriasis of the scap): NCT03123471","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0060","volume-title":"A phase 4 multicenter, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis: NCT03553433","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0061","volume-title":"The AP-GELP Study: a randomized, placebo-controlled clinical trial on the effects of phosphodiesterase 4-inhibitor apremilast in female genital erosive lichen planus: NCT03656666","author":"ClinicalTrials.gov.","year":"2018"},{"key":"CIT0062","volume-title":"A pilot study evaluating the efficacy of apremilast in the treatment of subjects with severe Recurrent Aphthous Stomatitis (RAS): NCT03690544","author":"ClinicalTrials.gov.","year":"2018"},{"key":"CIT0063","volume-title":"Apremilast as anti-pruritic treatment in patients with prurigo nodularis: NCT03576287","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0064","volume-title":"An open label, single center study to assess the safety and efficacy of a 24 week treatment course of CC-10004 in adults with recalcitrant prurigo nodularis: NCT00869089","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0065","volume-title":"Open label trial evaluating the efficacy of apremilast for the treatment of frontal fibrosing alopecia: NCT03422640","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0066","volume-title":"An open-label pilot study to investigate the efficacy of apremilast in the treatment of Central Centrifugal Cicatricial Alopecia (CCCA): NCT03521687","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0067","volume-title":"An open label study of apremilast in chronic idiopathic pruritus: NCT03239106","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0068","volume-title":"An open-label, single-arm pilot study investigating the efficacy and safety of apremilast for the treatment of moderate to severe chronic hand dermatitis: NCT03741933","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0069","volume-title":"A phase 2, open label single arm study for evaluating safety & efficacy of apremilast in the treatment of cutaneous disease in patients with recalcitrant dermatomyositis: NCT03529955","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0070","volume-title":"An open label study evaluating the safety and efficacy of apremilast in the treatment of cutaneous disease in patients with dermatomyositis: NCT01140503","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0071","volume-title":"An investigator-initiated, randomized, double-blind, placebo controlled study of apremilast to demonstrate efficacy in subjects with nummular eczema: NCT03160248","author":"ClinicalTrials.gov","year":"2017"},{"key":"CIT0072","volume-title":"A split body study of the effects of combined therapy with narrow-band ultraviolet B phototherapy and apremilast for the treatment of vitiligo: NCT03123016","author":"ClinicalTrials.gov","year":"2018"},{"key":"CIT0073","volume-title":"Repigmentation using apremilast and phototherapy in diffuse VITILIGO (Rapid Vitiligo): NCT03036995","author":"ClinicalTrials.gov","year":"2018"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546634.2019.1589641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T13:59:55Z","timestamp":1721138395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546634.2019.1589641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,17]]}},"alternative-id":["10.1080\/09546634.2019.1589641"],"URL":"https:\/\/doi.org\/10.1080\/09546634.2019.1589641","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-10-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}